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patients whose cases were reported in
2001 had no substantial travel history
and likely acquired the infection with-
in Singapore, as our patient did.
However, the lack of diagnostic test-
ing by local service microbiology lab-
oratories has possibly led to under-
diagnoses of this disease. 
While abolishment of pig farming
in Singapore has greatly reduced the
risk for epidemic transmission of JEV,
a seroepidemiologic study on the
prevalence of neutralizing antibodies
to JEV in local animals (including
dogs, cattle, goats, imported pigs,
chickens, and crows) showed a JEV
antibody prevalence of 46.5% in
working dogs and 60% in chickens.
These findings suggest that JEV
remains active in Singapore (5). The
virus reservoir is likely to be aquatic
birds. The threat of JE remains, and
public health vigilance for this vector-
borne disease should not diminish. 
The infrequent incidence of JE in
Singapore is insufficient to justify
routine vaccination for travelers to
this country. However, JE remains a
rare differential diagnosis for travelers
from or passing through Singapore.
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HIV and Lacaziosis,
Brazil
To the Editor: Jorge Lobo disease
(lacaziosis) is a chronic deep mycosis
for which prognosis is good in terms
of survival but unclear in terms of
regression of the lesions (1). No
involvement of internal organs or
mucous membranes is observed. The
causative agent is Lacazia loboi (2), a
fungus of uncertain phylogeny, which
causes an inflammatory infiltrate
accompanied by the formation of a
granuloma in which giant cells phago-
cytose a larger number of fungi (3,4).
Pecher and Funchs suggested that
patients with lacaziosis have a cellular
immunodeficiency (5). The disease is
more frequent in men and persons
21–40 years of age. It is found exclu-
sively in Latin America; only 1 case
has been diagnosed in Europe, and
that was due to accidental contamina-
tion with material from a dolphin (4).
Trauma and injuries or sites of
insect bites facilitate penetration of
the fungus. Lesion progression is
slow, with new lesions arising by con-
tiguity with other lesions or through
the lymphatic route (6,7). Clinically,
lacaziosis manifests as keloidal
lesions of solid consistency and vari-
able size that contain small scales and
crusts (6). The lesions are most fre-
quently located in the auricle and on
the upper and lower limbs. Cutaneous
dissemination of the disease is
observed in a relatively small number
of cases. We describe a patient with
Jorge Lobo disease.
The patient was a 59-year-old
man, a storeroom employee, who was
seen at the Tropical Medical Center in
Belem, Brazil, in April 2004. A papu-
la had developed near his right knee in
1992 after a wood splinter had pene-
trated the skin. The lesion increased in
size, and a histopathologic diagnosis
of Jorge Lobo disease was made. The
lesion was then surgically removed.
Approximately 2 years later, the
lesion recurred. The patient then went
to a dermatology service and was
treated with clofazimine, after which
the lesion disappeared. However, the
lesion reappeared 1 year later.
HIV serologic analysis was per-
formed in 2002, and the results were
positive. The patient then began treat-
ment for HIV infection. He is current-
ly being monitored at the specialized
referral unit in Belem. He does not
have any opportunistic infections and
is not taking any antiretroviral drugs.
The patient came to the dermatology
service of the Tropical Medical
Center, where dermatologic and
histopathologic examinations were
conducted and CD cell counts and
HIV viral load were measured.
Dermatologic aspects of the lesion
included an erythematous-infiltrated,
hypertrophic plaque with a verrucous
surface ≈4 cm long in the distal third
of the medial aspect of the right thigh
(Figure). A punch biopsy specimen of
brown smooth skin 0.35 cm in diame-
ter in an epidermal disk was fixed in
formalin. Microscopy of skin sections
containing epidermis showed com-
pact keratinization, parakeratotic foci,LETTERS
and irregular hyperplasia with a pseu-
doepitheliomatous area. A highly
dense, nodular, diffuse inflammatory
infiltrate was observed at all levels of
the dermis. It consisted of
macrophages and numerous multinu-
cleated cells, most of them of the for-
eign body type. Fibroplasia was also
noted. Abundant, round parasitic ele-
ments surrounded by a double mem-
brane and containing a basophilic
nucleus were found in tissues, as well
as other anucleated, intracellular, and
free parasites that formed chains of
>2 cells (online Appendix Figure,
available from http://www.cdc.gov/
ncidod/EID/vol12no03/05-1426_
appG. htm). Jorge Lobo disease was
diagnosed. Laboratory results showed
146 CD4 cells/µL, 251 CD8 cells/µL,
a CD4:CD8 ratio of 0.42, and 60,000
copies of HIV viral RNA/mL.
Since a cytotoxic response is
observed in Jorge Lobo disease (7),
HIV infection may increase the sus-
ceptibility to infection with L. loboi.
Patients with AIDS show a predispo-
sition to diverse fungal infections that
classically affect different organs and
systems. An association between
Jorge Lobo disease and AIDS has not
been reported. However, since Jorge
Lobo disease is restricted to specific
areas of the world and the number of
AIDS cases is increasing, especially
in Latin America, a possible correla-
tion between HIV infection and Jorge
Lobo disease should be considered
because of the associated cellular
immunodeficiency. 
The patient showed no signs of
other opportunistic infections classi-
cally associated with AIDS, and he
was not taking any antiretroviral
drugs. His initial infection manifested
as cutaneous lesions that occur in
Jorge Lobo disease. Despite the cellu-
lar immunodeficiency, we did not
observe atypical dissemination of the
lesions. Further studies should be con-
ducted to evaluate the relationship
between the cellular immunosuppres-
sion of AIDS and secondary infection
with L. loboi. In addition, epidemio-
logic studies are needed to determine
the association of AIDS with Jorge
Lobo disease.
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Hand Sanitizer
Alert
To the Editor: Community-based
epidemiologic studies have shown
beneficial effects of hand sanitizers.
Hand sanitizers were effective in
reducing gastrointestinal illnesses in
households (1), in curbing absentee
rates in elementary schools (2), and in
reducing illnesses in university dormi-
tories (3). An Internet search retrieved
recommendations for hand hygiene
from schools, daycare centers, outdoor
guides, and animal shelters.
To reduce infections in healthcare
settings, alcohol-based hand sanitiz-
ers are recommended as a component
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Figure. Erythematous-infiltrated, hypertrophic plaque with a verrucous surface ≈4 cm long
in the distal third of the medial aspect of the right thigh of the patient. 